The table below shows MADRIGAL PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
$137.25M
-
-
Cost of revenue
-
-
-
$4.51M
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
$268.52M
MDGL annual revenue (10-K history)
MADRIGAL PHARMACEUTICALS, INC. reported annual revenue of $958.40M for fiscal year 2025. That is up 432.1% from $180.13M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $147.00K (FY 2012) to $958.40M. Figures come from the company's audited annual reports as filed with the SEC.